North Star Investment Management Corp. - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$66
+32.0%
3150.0%0.00%
Q1 2023$50
-71.4%
3150.0%0.00%
Q4 2022$1753150.0%0.00%
Q3 2022$03150.0%0.00%
Q2 2022$03150.0%0.00%
Q1 2022$0
-100.0%
3150.0%0.00%
Q4 2021$1,0000.0%3150.0%0.00%
Q3 2021$1,0000.0%3150.0%0.00%
Q2 2021$1,0000.0%3150.0%0.00%
Q1 2021$1,0000.0%3150.0%0.00%
Q4 2020$1,0003150.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders